US4305958AExpiredUtility

Cysteine derivatives

Assignee: SANTEN PHARMACEUTICAL CO LTDPriority: Mar 8, 1976Filed: Feb 24, 1977Granted: Dec 15, 1981

Est. expiryMar 8, 1996(expired)· nominal 20-yr term from priority

Inventors:Tadashi Fujita Masayuki Oya Hideo Takashina Tadashi Iso

A61P 11/00A61P 11/10A61K 31/195

PatentIndex Score

Cited by

References

Claims

Abstract

This invention relates to the compounds: N-(mercaptoacy)-cysteine represented by the following formula wherein Z is selected from the group consisting of CH 3 --CH<, (CH 3 ) 2 C<, (CH 2 ) 2 < and CH 2 <, acting as agents for the liquefaction of sputum, intermediate therefor and a process for manufacture thereof. ##STR1##

Claims

exact text as granted — not AI-modified

What is claimed is: 
     
       1. N-(2-mercaptoisobutyryl)-cysteine. 
     
     
       2. N-(2-mercaptopropionyl)-cysteine. 
     
     
       3. A composition for the liquefaction of sputum containing an effective amount of the N-(mercaptoacyl)-cysteine having the formula ##STR3## and a medicinal carrier. 
     
     
       4. A composition for the liquefaction of sputum containing an effective amount of the N-(mercaptoacyl)-cysteine having the formula ##STR4## and a medicinal carrier.

Join the waitlist — get patent alerts

Track US4305958A — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.